Physician

Erik Stephen Cabral, M.D.

According to 2025 Medicare claims, Erik Cabral, M.D. (NPI: 1023252350) practices micrographic dermatologic surgery in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is ARTIUS DERMATOLOGY ASSOCIATES, P.C. (NPI: 1245782291; TIN: 81-4228704) and primary practice location at 94538-1614.

Cabral's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 402 traditional Medicare patients, billed 18,698 HCPCS/CPT codes, and received $508,363 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 654 prescription claims across 262 beneficiaries totaling $17,766 in drug costs, led by Fluocinonide (Fluocinonide). Open Payments data shows 5 records totaling $100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $7,458 and ending at $508,363. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $51,892 to $17,766. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	78	164	$7,458
2016	N/R	N/R	N/R
2017	634	7,617	$456,832
2018	796	9,710	$667,626
2019	819	7,854	$744,699
2020	557	5,291	$577,398
2021	726	4,321	$768,337
2022	332	1,448	$213,888
2023	418	6,975	$337,347
2024	402	18,698	$508,363

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	295	742	$51,892
2016	395	668	$60,001
2017	322	563	$54,562
2018	244	502	$25,920
2019	210	433	$17,891
2020	170	333	$12,184
2021	321	506	$23,054
2022	158	264	$11,397
2023	249	530	$31,777
2024	262	654	$17,766

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	187	216	$499
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	77	128	$401
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	244	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	174	$77
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	68	82	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluocinonide	Fluocinonide	79	2,721	$5,481
Tacrolimus	Tacrolimus	28	730	$2,511
Gentamicin Sulfate	Gentamicin Sulfate	39	1,059	$1,392
Mupirocin	Mupirocin	131	2,995	$949
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	21	520	$939

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$100	MIMEDX Group, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Erik Stephen Cabral, M.D.?

Tedicare shows public-source Medicare data for Erik Stephen Cabral, M.D. (NPI 1023252350), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erik Stephen Cabral, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Erik Stephen Cabral, M.D.?

Erik Stephen Cabral, M.D. is linked to ARTIUS DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1245782291) in the available physician profile data.

Does Erik Stephen Cabral, M.D. have Open Payments data?

Erik Stephen Cabral, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.